Trade
Trading Type
Spot
Trade crypto freely
Alpha
Points
Get promising tokens in streamlined on-chain trading
Pre-Market
Trade new tokens before they are officially listed
Margin
Magnify your profit with leverage
Convert & Block Trading
0 Fees
Trade any size with no fees and no slippage
Leveraged Tokens
Get exposure to leveraged positions simply
Futures
Futures
Hundreds of contracts settled in USDT or BTC
Options
HOT
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Futures Kickoff
Get prepared for your futures trading
Futures Events
Participate in events to win generous rewards
Demo Trading
Use virtual funds to experience risk-free trading
Earn
Launch
Investment
Simple Earn
VIP
Earn interests with idle tokens
Auto-Invest
Auto-invest on a regular basis
Dual Investment
Buy low and sell high to take profits from price fluctuations
Quant Fund
VIP
Top asset management team helps you profit without hassle
Crypto Loan
0 Fees
Pledge one crypto to borrow another
Lending Center
One-Stop Lending Hub
VIP Wealth Hub
New
Customized wealth management empowers your assets growth
Staking
Stake cryptos to earn in PoS products
BTC Staking
HOT
Stake BTC and earn 10% APR
ETH Staking
HOT
Stake ETH and earn 6% APR
GUSD Minting
New
Use USDT/USDC to mint GUSD for treasury-level yields
Soft Staking
Earn rewards with flexible staking
More
- Trending TopicsView More
16k Popularity
24k Popularity
52k Popularity
270k Popularity
53k Popularity
- Pin
- 🚀 Gate $PUMP Futures Trading Challenge is Now Live!
Trade & check in daily to earn 370 USDT — join now: https://www.gate.com/campaigns/2001
Share a 50,000 USDT Prize Pool
🎯 Earn daily check-in rewards, deposit to claim airdrops, plus exclusive perks for all
Announcement link: https://www.gate.com/announcements/article/47104 - 🌕 Gate Square · Mid-Autumn Creator Incentive Program is Now Live!
Share your creations with trending topics and get a chance to split $5,000 in rewards! 🎁
👉 Join now: https://www.gate.com/campaigns/1953
💡 How to Join:
1️⃣ Post with the hashtag #Gate Square Mid Autumn Creator Incentive# .
2️⃣ Your content should follow the daily trending topics posted by [Gate _Square], and include both hashtags.
3️⃣ The more posts, higher quality, and greater engagement — the bigger your rewards! 🚀
💰 Creator Rewards:
🏆 Top 1: Bulgari Mid-Autumn Gift Box + $100 Futures Voucher + $100 GT
🥈 Top 2: Bulgari - 🎉【Gate Singapore Flagship Event · Square Fun Quiz Challenge Day 1】
#TOKEN2049# is just around the corner, and Gate is bringing the heat to Singapore!
Token of Love Music Festival, Gate x Oracle Red Bull Racing Reception, and the F1 Race Viewing are all set to roll out!
Join Square Fun Quiz Challenge now, test how much you know about the events and share $100 BTC in rewards!
To join: Comment your answers (format: 1B 2A 3B 4C)
🎁 Rewards: 3 lucky winners each day → $10 BTC each
👑 Bonus: Answer all questions correctly for 3 days → Extra $10 BTC for Super Quiz King!
📖 Day 1 · Quiz (Single Choic - 💥 Gate Square Event: #SOMI Creative Contest# 💥
Post original content related to SOMI or CandyDrop #76 on Gate Square for a chance to share 180 SOMI rewards!
CandyDrop 76: CandyDrop x Somnia (SOMI)👉 https://www.gate.com/announcements/article/46912
📅 Event Period: Sep 8, 2025 – Sep 15, 2025
📌 How to Participate:
Post original content related to SOMI or the CandyDrop event
Minimum 80 words
Add hashtag: #SOMI Creative Contest#
Include CandyDrop participation screenshot
🏆 Rewards:
🥇 1st Prize (1 winner): 60 SOMI
🥈 2nd Prize (3 winners): 30 SOMI each
🥉 3rd Prize (6 winners): 10 SOMI each
(T - 🚗 #GateSquareCommunityChallenge# Round 1 — Who Will Be The First To The Moon?
Brain challenge, guess and win rewards!
5 lucky users with the correct answers will share $50 GT! 💰
Join:
1️⃣ Follow Gate_Square
2️⃣ Like this post
3️⃣ Drop your answer in the comments
📅 Ends at 16:00, Sep 17 (UTC)
Global Real-World Study Results of the Largest-scale JAK1 Inhibitor Released
On March 8th, Jinshi Data reported that at the recent AAD meeting in the United States, the interim results of the world's largest JAK1 inhibitor, Abrocitinib, in the real world study AHEAD (Abrocitinib CHinese rEgistry on AD) were internationally released. This provides more real-world research and medical evidence data for the innovative small molecule drug with high selectivity JAK1 inhibitor in the field of atopic dermatitis (AD), further strengthening the clinical scientific basis to optimize treatment strategies and drive the reshaping of AD diagnosis and treatment pathways.